Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Malapelle

Showing results (1-10 of 376) with videos related to

Pageof 38
Sort By:
Ebiomedicine|September 21, 2019
USP11 role in colorectal cancer growing and metastatisationUmberto Malapelle
Translational Cancer Research|February 4, 2022
Targeted therapy and non-small cell lung cancer: a new era!Umberto Malapelle, Christian Rolfo
Critical Reviews in Oncology/Hematology|February 5, 2025
Next-generation sequencing for PTEN testing in HR+/HER2- metastatic breast cancerNicola Fusco, Umberto Malapelle
Frontiers in Oncology|December 8, 2022
Editorial: Molecular pathology and computational image analyses in gynecologic malignanciesUmberto Malapelle, Sandra Orsulic
The Lancet Regional Health. Europe|March 13, 2024
Biomarker testing in patients with advanced non-small cell lung cancer: the never-ending storyUmberto Malapelle, Silvia Novello
Ebiomedicine|August 12, 2022
A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinibUmberto Malapelle, Francesco Passiglia
Frontiers in Oncology|December 29, 2022
Editorial: Long non-coding RNAs in lung cancerUmberto Malapelle, Giulia Veronesi
Epigenomics|January 3, 2024
Dissecting the nuances of cancer epigenomics in liquid biopsyValerio Gristina, Umberto Malapelle
Expert Opinion on Emerging Drugs|May 17, 2019
Emerging angiogenesis inhibitors for non-small cell lung cancerUmberto Malapelle, Antonio Rossi
Frontiers in Medicine|June 8, 2017
Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising DrugsUmberto Malapelle, Pierlorenzo Pallante
Pageof 38

Showing results (1-10 of 376) with videos related to

Sort By:
Pageof 38
Ebiomedicine|September 21, 2019
USP11 role in colorectal cancer growing and metastatisationUmberto Malapelle
Translational Cancer Research|February 4, 2022
Targeted therapy and non-small cell lung cancer: a new era!Umberto Malapelle, Christian Rolfo
Critical Reviews in Oncology/Hematology|February 5, 2025
Next-generation sequencing for PTEN testing in HR+/HER2- metastatic breast cancerNicola Fusco, Umberto Malapelle
Frontiers in Oncology|December 8, 2022
Editorial: Molecular pathology and computational image analyses in gynecologic malignanciesUmberto Malapelle, Sandra Orsulic
The Lancet Regional Health. Europe|March 13, 2024
Biomarker testing in patients with advanced non-small cell lung cancer: the never-ending storyUmberto Malapelle, Silvia Novello
Ebiomedicine|August 12, 2022
A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinibUmberto Malapelle, Francesco Passiglia
Frontiers in Oncology|December 29, 2022
Editorial: Long non-coding RNAs in lung cancerUmberto Malapelle, Giulia Veronesi
Epigenomics|January 3, 2024
Dissecting the nuances of cancer epigenomics in liquid biopsyValerio Gristina, Umberto Malapelle
Expert Opinion on Emerging Drugs|May 17, 2019
Emerging angiogenesis inhibitors for non-small cell lung cancerUmberto Malapelle, Antonio Rossi
Frontiers in Medicine|June 8, 2017
Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising DrugsUmberto Malapelle, Pierlorenzo Pallante
Pageof 38